In the BioHarmony Drug Report Database
Brimonidine
Alphagan, Alphagan P, Lumify, Mirvaso, Qoliana (brimonidine) is a small molecule pharmaceutical. Brimonidine was first approved as Alphagan on 1996-09-06. It is used to treat open-angle glaucoma in the USA. It has been approved in Europe to treat skin diseases. The pharmaceutical is active against alpha-2B adrenergic receptor, alpha-2A adrenergic receptor, and alpha-2C adrenergic receptor. Alphagan p’s patents are valid until 2031-06-13 (FDA).
Trade Name
|
Mirvaso |
|---|---|
Common Name
|
brimonidine |
ChEMBL ID
|
CHEMBL844 |
Indication
|
open-angle glaucoma, skin diseases |
Drug Class
|
Image (chem structure or protein)